The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
SII‐ChAdOx1 – Serum Institute of India/AstraZeneca + University of… probably leads to lower systemic reactogenicity eventsb compared with chAdOx1 – University of Oxford (moderate certainty).
SII‐ChAdOx1 – Serum Institute of India/AstraZeneca + University of… showed no clear difference in any adverse evente compared with chAdOx1 – University of Oxford (low certainty).
SII‐ChAdOx1 – Serum Institute of India/AstraZeneca + University of… showed no clear difference in serious adverse eventsg compared with chAdOx1 – University of Oxford (low certainty).
SII‐ChAdOx1 – Serum Institute of India/AstraZeneca + University of… showed no clear difference in local reactogenicity eventsb compared with chAdOx1 – University of Oxford (low certainty).